Showing results (571-580 of 2,992) with videos related to
Sort By:
Pageof 300
Seminars in Thrombosis and Hemostasis|February 6, 2014
Validation of hemostasis and coagulation assays: recommendations and guidelinesRichard A Marlar, Jana N Gausman, James W EngelSeminars in Thrombosis and Hemostasis|February 6, 2014
The UK National External Quality Assessment Scheme for heritable bleeding disordersDavid J Perry, Tony Cumming, Anne Goodeve, et al.Seminars in Thrombosis and Hemostasis|March 29, 2014
Current status of use of erythropoietic agents in cancer patientsJohn GlaspySeminars in Thrombosis and Hemostasis|July 1, 1985
Hemostasis changes during cardiopulmonary bypass surgeryE F Mammen, M H Koets, B C Washington, et al.Seminars in Thrombosis and Hemostasis|May 7, 2014
Genetics of atypical hemolytic uremic syndrome (aHUS)Santiago Rodríguez de Córdoba, Marta Subías Hidalgo, Sheila Pinto, et al.Seminars in Thrombosis and Hemostasis|October 1, 1989
Synopsis of the anticoagulant and antithrombotic profile of the low molecular weight heparinoid Org 10172 in experimental modelsD G MeulemanSeminars in Thrombosis and Hemostasis|April 1, 1985
Usefulness of fibrinopeptide A generation tests in experimental and clinical studies with low molecular weight heparin fractionsR M Emanuele, J Fareed, J M Walenga, et al.Seminars in Thrombosis and Hemostasis|April 1, 1985
An objective assessment of the interaction of heparin and its fractions with human plateletsL D Brace, J FareedSeminars in Thrombosis and Hemostasis|April 9, 2008
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIaJob Harenberg, Martin WehlingSeminars in Thrombosis and Hemostasis|April 9, 2008
Survival of heparins, oral anticoagulants, and aspirin after the year 2010Jawed Fareed, Debra A Hoppensteadt, Daniel Fareed, et al.Pageof 300